Evidence map›Paper›PMID 34946200›Full record

ArticleMicroorganisms2021

Assessing Gut Microbiota in an Infant with Congenital Propionic Acidemia before and after Probiotic Supplementation.

Andrea Bordugo, Elisa Salvetti, Giulia Rodella, Michele Piazza, Alice Dianin, Angela Amoruso, Giorgio Piacentini, Marco Pane, Sandra Torriani, Nicola Vitulo and 1 more

Open access · goldAbstract readCase Reports
In one paragraph

Article in Microorganisms, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 11 citations in OpenAlex.

  1. Immune Dysregulation in Branched Chain Organic Acidemias.Journal of inherited metabolic disease · 2026
    Review
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Andrea BordugoInherited Metabolic Disease Unit, Pediatric Clinic C, Azienda Ospedaliera Università Integrata, Piazzale Stefani 1, 37126 Verona, Italy.ORCID 0000-0003-1927-8187
Elisa SalvettiDepartment of Biotechnology, University of Verona, Strada le Grazie 15, 37134 Verona, Italy.
Giulia RodellaInherited Metabolic Disease Unit, Pediatric Clinic C, Azienda Ospedaliera Università Integrata, Piazzale Stefani 1, 37126 Verona, Italy.
Michele PiazzaDepartment of Surgery, Dentistry, Paediatrics and Gynaecology, University of Verona, Piazzale Stefani 1, 37126 Verona, Italy.ORCID 0000-0001-7746-8267
Alice DianinInherited Metabolic Disease Unit, Pediatric Clinic C, Azienda Ospedaliera Università Integrata, Piazzale Stefani 1, 37126 Verona, Italy.
Angela AmorusoProbiotical Research Srl, Via Enrico Mattei 3, 28100 Novara, Italy.
Giorgio PiacentiniDepartment of Surgery, Dentistry, Paediatrics and Gynaecology, University of Verona, Piazzale Stefani 1, 37126 Verona, Italy.
Marco PaneProbiotical Research Srl, Via Enrico Mattei 3, 28100 Novara, Italy.
Sandra TorrianiDepartment of Biotechnology, University of Verona, Strada le Grazie 15, 37134 Verona, Italy.ORCID 0000-0002-2565-7557
Nicola VituloDepartment of Biotechnology, University of Verona, Strada le Grazie 15, 37134 Verona, Italy.ORCID 0000-0002-9571-0747
Giovanna E FelisDepartment of Biotechnology, University of Verona, Strada le Grazie 15, 37134 Verona, Italy.
University of Verona · ITAzienda Ospedaliera Universitaria Integrata Verona · ITProbiotical (Italy) · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Propionic Acidemia (PA) is a rare inherited metabolic disorder caused by the enzymatic block of propionyl-CoA carboxylase with the consequent accumulation of propionic acid, which is toxic for the brain and cardiac cells. Since a considerable amount of propionate is produced by intestinal bacteria, interest arose in the attempt to reduce propionate-producing bacteria through a monthly antibiotic treatment of metronidazole. In the present study, we investigated the gut microbiota structure of an infant diagnosed at 4 days of life through Expanded Newborn Screening (NBS) and treated the child following international guidelines with a special low-protein diet, specific medications and strict biochemical monitoring. Microbiota composition was assessed during the first month of life, and the presence of

Indexed as

Bacteroides fragilisbifidobacteriaBifidobacterium brevedietelectronic nosegeneticgut microbiotainherited metabolic diseasesmetabarcodingmetagenomicsmetronidazoleorganic aciduriasprobiotic supplementationpropionic acidpropionic acidemiaRuminococcus gnavusVOC

Identifiers

PMID34946200
PMCPMC8703847
OpenAlexW4200130375

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.